Tekmira Pharmaceuticals (TKMR) Up 20 percent on News

Tekmira Pharmaceuticals Corporation (TKMR) is spiking in early trading today after the company announced that the U.S. Food and Drug Administration has verbally confirmed they have modified the full clinical hold placed on the company’s TKM-Ebola Phase 1 Ebola treatment to a partial clinical hold. This action enables the potential use of TKM-Ebola in individuals […] View the full post at: Tekmira Pharmaceuticals (TKMR) Up 20 percent on News Related posts: GDP Data: The Bad News Continues More Bad News Blows in for Wind Power
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.